Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Health Reform Update: Public Plan Compromise Seems Close – Now The Fun Really Begins

This article was originally published in The Pink Sheet Daily

Executive Summary

After a compromise on government-run insurance model, focus will shift squarely to paying for universal coverage. How much will biopharma sector be asked to give?

You may also be interested in...



“Co-op Insurance” Emerges As Alternative To Health Reform Public Plan, But What Is It?

Republicans are reportedly open to providing a cooperative insurance plan as an alternative to a public plan as part of the expansion of health care coverage.

Health Reform Details Emerge: Get Ready for Medicare Part D Rebates, Follow-on Biologics

House Energy and Commerce health reform bill will likely include a minimum rebate for Medicare Part D dual-eligibles.

Public Plan Consensus Possible? Daschle Offers A “Qualified Yes”

A "common ground" solution is possible for the most controversial issue in the health care reform debate - whether to establish a government-run insurance plan that would compete with private plans - according to former Sen. Tom Daschle

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS069550

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel